Logo image of OPTN

OPTINOSE INC (OPTN) Stock Fundamental Analysis

NASDAQ:OPTN - Nasdaq - US68404V2097 - Common Stock - Currency: USD

9.17  +0.01 (+0.11%)

Fundamental Rating

2

Overall OPTN gets a fundamental rating of 2 out of 10. We evaluated OPTN against 198 industry peers in the Pharmaceuticals industry. OPTN may be in some trouble as it scores bad on both profitability and health. OPTN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OPTN has reported negative net income.
In the past year OPTN has reported a negative cash flow from operations.
OPTN had negative earnings in each of the past 5 years.
OPTN had a negative operating cash flow in each of the past 5 years.
OPTN Yearly Net Income VS EBIT VS OCF VS FCFOPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of OPTN (-27.65%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -27.65%
ROE N/A
ROIC N/A
ROA(3y)-33.85%
ROA(5y)-40.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPTN Yearly ROA, ROE, ROICOPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

With an excellent Gross Margin value of 90.91%, OPTN belongs to the best of the industry, outperforming 91.41% of the companies in the same industry.
OPTN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OPTN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.39%
OPTN Yearly Profit, Operating, Gross MarginsOPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

1

2. Health

2.1 Basic Checks

OPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPTN has been increased compared to 1 year ago.
Compared to 5 years ago, OPTN has less shares outstanding
The debt/assets ratio for OPTN has been reduced compared to a year ago.
OPTN Yearly Shares OutstandingOPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OPTN Yearly Total Debt VS Total AssetsOPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

OPTN has an Altman-Z score of -7.98. This is a bad value and indicates that OPTN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.98, OPTN is doing worse than 69.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.98
ROIC/WACCN/A
WACC14.62%
OPTN Yearly LT Debt VS Equity VS FCFOPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

OPTN has a Current Ratio of 0.77. This is a bad value and indicates that OPTN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.77, OPTN is not doing good in the industry: 88.38% of the companies in the same industry are doing better.
A Quick Ratio of 0.70 indicates that OPTN may have some problems paying its short term obligations.
OPTN has a worse Quick ratio (0.70) than 86.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
OPTN Yearly Current Assets VS Current LiabilitesOPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for OPTN have decreased strongly by -706.25% in the last year.
Looking at the last year, OPTN shows a very strong growth in Revenue. The Revenue has grown by 31.16%.
OPTN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.70% yearly.
EPS 1Y (TTM)-706.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)31.16%
Revenue growth 3Y1.57%
Revenue growth 5Y17.7%
Sales Q2Q%12.85%

3.2 Future

OPTN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.80% yearly.
OPTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.27% yearly.
EPS Next Y0.24%
EPS Next 2Y16%
EPS Next 3Y23.1%
EPS Next 5Y16.8%
Revenue Next Year27.03%
Revenue Next 2Y20.08%
Revenue Next 3Y20.15%
Revenue Next 5Y23.27%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPTN Yearly Revenue VS EstimatesOPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
OPTN Yearly EPS VS EstimatesOPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OPTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPTN Price Earnings VS Forward Price EarningsOPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPTN Per share dataOPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as OPTN's earnings are expected to grow with 23.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16%
EPS Next 3Y23.1%

More info and screens

0

5. Dividend

5.1 Amount

OPTN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTINOSE INC

NASDAQ:OPTN (4/17/2025, 8:00:02 PM)

9.17

+0.01 (+0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-26 2025-03-26/bmo
Earnings (Next)05-12 2025-05-12/bmo
Inst Owners77.15%
Inst Owner Change0.06%
Ins Owners5.94%
Ins Owner Change1.57%
Market Cap92.80M
Analysts78
Price Target18.36 (100.22%)
Short Float %2.6%
Short Ratio6.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)97.92%
Min EPS beat(2)95.84%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)55.74%
Min EPS beat(4)-9.44%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)43.09%
EPS beat(12)9
Avg EPS beat(12)28.95%
EPS beat(16)12
Avg EPS beat(16)23.64%
Revenue beat(2)0
Avg Revenue beat(2)-6.85%
Min Revenue beat(2)-12.9%
Max Revenue beat(2)-0.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-12.9%
Max Revenue beat(4)8.75%
Revenue beat(8)5
Avg Revenue beat(8)3.07%
Revenue beat(12)5
Avg Revenue beat(12)-0.66%
Revenue beat(16)8
Avg Revenue beat(16)-0.45%
PT rev (1m)-24.21%
PT rev (3m)500%
EPS NQ rev (1m)1.33%
EPS NQ rev (3m)-1380%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-2703.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-8.48%
Revenue NY rev (3m)-8.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.58
EYN/A
EPS(NY)-2.57
Fwd EYN/A
FCF(TTM)-4.42
FCFYN/A
OCF(TTM)-4.42
OCFYN/A
SpS9.2
BVpS-3.99
TBVpS-3.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.91%
FCFM N/A
ROA(3y)-33.85%
ROA(5y)-40.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.39%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.44%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z -7.98
F-Score5
WACC14.62%
ROIC/WACCN/A
Cap/Depr(3y)39.45%
Cap/Depr(5y)36.44%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-706.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y0.24%
EPS Next 2Y16%
EPS Next 3Y23.1%
EPS Next 5Y16.8%
Revenue 1Y (TTM)31.16%
Revenue growth 3Y1.57%
Revenue growth 5Y17.7%
Sales Q2Q%12.85%
Revenue Next Year27.03%
Revenue Next 2Y20.08%
Revenue Next 3Y20.15%
Revenue Next 5Y23.27%
EBIT growth 1Y-7.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.61%
OCF growth 3YN/A
OCF growth 5YN/A